Ann: Response to ASX Query Letter, page-255

First 255 Last

Share
Profile

Follow
geeesss

18 Posts.

9

28/10/19

22:14

Post #: 41109349
Share

Originally posted by OzJ ↑

Sheesh, Ok.

In this notice (https://asic.gov.au/about-asic/news...arkets-ot-markets-and-ozifin-trade-financial/) ASIC say (notice comes from today's announcment):

In today's announcement, ISX says:

So ISX was trading with OT Capital AFTER ASIC issued a warning not to.

Additionally, in the ASIC announcement we this this notice that OT Capital bank account was frozen and provisional administrators requested in April '18.

You'll notice here in today's announcement that ISX is aware of the relationships between these companies.

Interestingly, somehow ISX continue doing business with these companies despite the frozen bank accounts and provisional administrators being requested according to today's announcement.

Remembering that 23% of ISX revenue came from OT Capital alone that trading was occurring AFTER both the Feb and Apr ASIC announcements.

Really, all this information is there for those motivated enough to search for it and willing enough to see it. I do this just because it's interesting. I would think that you do it because you have an actual interest. But instead you slander and fight it every step of the way. That's fine. I don't really mind. But don't think you're a hero. You're just unwilling to do the work required to chase this and stay in front of where it is going.

Expand

Where is the proof for your statement, specifically that trading occurred after the ASIC warnings? That they've included revenue in the 6 months to June 30 doesn't prove your allegation 'that trading was occurring AFTER both the Feb and Apr ASIC announcements." ?

ISX Price at posting: $1.07 Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Failure to report prompts ASX to impose multiple company suspensions

IRE

Iress runs 'hot' for Wealth Within's stock tips

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals